158 related articles for article (PubMed ID: 36088397)
1. Oral squamous cell carcinoma arising from chronic traumatic ulcers.
Gilligan G; Piemonte E; Lazos J; Simancas MC; Panico R; Warnakulasuriya S
Clin Oral Investig; 2023 Jan; 27(1):193-201. PubMed ID: 36088397
[TBL] [Abstract][Full Text] [Related]
2. Clinical and Immunohistochemical epithelial profile of non-healing chronic traumatic ulcers.
Gilligan GM; Panico RL; Di Tada C; Piemonte ED; Brunotto MN
Med Oral Patol Oral Cir Bucal; 2020 Sep; 25(5):e706-e713. PubMed ID: 32683386
[TBL] [Abstract][Full Text] [Related]
3. Comparison of PD-L1 Expression in Oral Squamous Cell Carcinoma and Premalignant Lesions of Oral Cavity.
Saeed S; Rauf F; Iqbal F; Khan AS; Khan AH; Alamgeer R
Asian Pac J Cancer Prev; 2022 Dec; 23(12):4039-4045. PubMed ID: 36579984
[TBL] [Abstract][Full Text] [Related]
4. Oral Squamous Cell Carcinoma Associated with Precursor Lesions.
McCord C; Kiss A; Magalhaes MA; Leong IT; Jorden T; Bradley G
Cancer Prev Res (Phila); 2021 Sep; 14(9):873-884. PubMed ID: 34193432
[TBL] [Abstract][Full Text] [Related]
5. Malignant transformation in 5071 southern Taiwanese patients with potentially malignant oral mucosal disorders.
Wang YY; Tail YH; Wang WC; Chen CY; Kao YH; Chen YK; Chen CH
BMC Oral Health; 2014 Aug; 14():99. PubMed ID: 25096230
[TBL] [Abstract][Full Text] [Related]
6. Immunoexpression profile of hypoxia-inducible factor (HIF) targets in potentially malignant and malignant oral lesions: a pilot study.
Gholami S; Chamorro-Petronacci C; Pérez-Sayáns M; Suárez Peñaranda J; Longatto-Filho A; Baltazar F; Afonso J
J Appl Oral Sci; 2023; 31():e20220461. PubMed ID: 37194791
[TBL] [Abstract][Full Text] [Related]
7. Revisiting the evidence of photodynamic therapy for oral potentially malignant disorders and oral squamous cell carcinoma: An overview of systematic reviews.
Schuch LF; Schmidt TR; Kirschnick LB; de Arruda JAA; Campagnol D; Martins MAT; Santos-Silva AR; Lopes MA; Vargas PA; Bagnato VS; Kurachi C; Guerra ENS; Martins MD
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103531. PubMed ID: 36963644
[TBL] [Abstract][Full Text] [Related]
8. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
9. Significance of nuclear EGFR and ABCG2 expression in malignant transformation of oral potentially malignant disorders.
Tarle M; Müller D; Raguž M; Lukšić I
Head Neck; 2022 Dec; 44(12):2668-2677. PubMed ID: 36325600
[TBL] [Abstract][Full Text] [Related]
10. Evolution tumour models paving the way for understanding oral carcinogenesis.
Martins-Chaves RR; Silva RSO; Pereira TDSF; Fonseca FP; Gomez RS
J Oral Pathol Med; 2023 Apr; 52(4):294-299. PubMed ID: 36622735
[TBL] [Abstract][Full Text] [Related]
11. Oral carcinogenesis and non-invasive biomarkers for the diagnosis of oral squamous cell carcinoma.
Khan S; Alamgir MM
J Pak Med Assoc; 2024 Feb; 74(2):370-373. PubMed ID: 38419239
[TBL] [Abstract][Full Text] [Related]
12. Progression to malignancy in oral potentially malignant disorders: a retrospective study of 5,036 patients in Ontario, Canada.
McCord C; Achita P; Kiss A; Magalhaes MA; Darling M; Bradley G
Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Oct; 136(4):466-477. PubMed ID: 37563059
[TBL] [Abstract][Full Text] [Related]
13. Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer.
Jäwert F; Nyman J; Olsson E; Adok C; Helmersson M; Öhman J
Oral Oncol; 2021 Oct; 121():105469. PubMed ID: 34371451
[TBL] [Abstract][Full Text] [Related]
14. Expression of Mucin1 in saliva in oral squamous cell carcinoma and oral potentially malignant disorders (case control study).
Abdelwhab A; Shaker O; Aggour RL
Oral Dis; 2023 May; 29(4):1487-1494. PubMed ID: 35080082
[TBL] [Abstract][Full Text] [Related]
15. Risk assessment of malignant transformation of oral leukoplakia in patients with previous oral squamous cell carcinoma.
Yang SW; Lee YC; Lee YS; Chang LC; Lai YR
Int J Oral Maxillofac Surg; 2022 Nov; 51(11):1394-1400. PubMed ID: 35249786
[TBL] [Abstract][Full Text] [Related]
16. Overestimated risk of transformation in oral lichen planus.
Cai X; Zhang J; Zhang H; Li T
Oral Oncol; 2022 Oct; 133():106025. PubMed ID: 35858493
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Salivary Electrolytes Profile in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Saavedra JA; Novo DR; Mesko MF; Uchoa Vasconcellos AC; Duarte Da Silva K; Rojas Zuñiga G; Ramires RF; Tarquinio SBC
Asian Pac J Cancer Prev; 2022 Mar; 23(3):1031-1039. PubMed ID: 35345377
[TBL] [Abstract][Full Text] [Related]
18. Malignant transformation in a cohort of patients with oral epithelial dysplasia.
Hankinson PM; Mohammed-Ali RI; Smith AT; Khurram SA
Br J Oral Maxillofac Surg; 2021 Nov; 59(9):1099-1101. PubMed ID: 34303542
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 expression in oral lichen planus, dysplastic lesions and squamous cell carcinoma.
Jaafari-Ashkavandi Z; Aslani E
Pathol Res Pract; 2017 Jul; 213(7):809-814. PubMed ID: 28554768
[TBL] [Abstract][Full Text] [Related]
20. Relationship of the XRCC1 rs25487 polymorphism with demographic, behavioral, clinical, and histological parameters in oral potentially malignant disorders and oral squamous cell carcinoma in a Colombian population.
Hernández-Arenas YY; Támara-De Ávila JJ; Isaza-Guzmán DM; González-Pérez LV; Tobón-Arroyave SI
J Oral Biosci; 2021 Jun; 63(2):217-223. PubMed ID: 33647453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
